Hydrix is one of the most undervalued shares in ASX and losing its ground after a credible hype in August 2020 where share price rose from $0.1 to its current level. The CEO has promised that 2021 will be a promising year but I don't see any energy in this share besides AngleMed is currently in process of getting a TGA approval. Historically, HYD was trading >$1 in 2018, however, it's products are yet to convince the market that it is a growth company. I'm losing my patience, but still hopeful that it could do better in 2021. Anyone can convince me that I should be still holding this share in 2021
Hydrix is one of the most undervalued shares in ASX and losing...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HYD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.050M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 44999 | 2 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| HYD (ASX) Chart |
Day chart unavailable